Burning Rock Biotech Limited
BNR
$9.02
$0.010.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.35% | -5.76% | -10.56% | -16.27% | -12.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.35% | -5.76% | -10.56% | -16.27% | -12.60% |
| Cost of Revenue | -13.17% | -13.44% | -9.25% | -10.34% | -9.10% |
| Gross Profit | 5.89% | -2.09% | -11.15% | -18.83% | -14.21% |
| SG&A Expenses | -41.00% | -35.14% | -27.87% | -21.65% | -32.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.29% | -31.77% | -27.14% | -22.90% | -27.09% |
| Operating Income | 65.33% | 52.68% | 40.01% | 27.90% | 36.19% |
| Income Before Tax | 60.67% | 48.61% | 40.88% | 28.68% | 37.26% |
| Income Tax Expenses | 175.52% | 143.77% | -49.93% | -33.36% | -12.55% |
| Earnings from Continuing Operations | 59.81% | 47.91% | 40.92% | 28.69% | 37.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 59.81% | 47.91% | 40.92% | 28.69% | 37.19% |
| EBIT | 65.33% | 52.68% | 40.01% | 27.90% | 36.19% |
| EBITDA | 75.14% | 62.06% | 49.39% | 35.42% | 43.10% |
| EPS Basic | 60.12% | 48.13% | 41.02% | 28.40% | 36.52% |
| Normalized Basic EPS | 85.01% | 70.21% | 55.85% | 42.00% | 36.59% |
| EPS Diluted | 60.12% | 48.13% | 41.02% | 28.40% | 36.52% |
| Normalized Diluted EPS | 85.01% | 70.21% | 55.85% | 42.00% | 36.59% |
| Average Basic Shares Outstanding | 1.72% | 0.52% | 0.29% | -0.31% | -0.92% |
| Average Diluted Shares Outstanding | 1.72% | 0.52% | 0.29% | -0.32% | -0.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |